73 related articles for article (PubMed ID: 16900480)
1. Routine vaginal Pap test is not useful in women status-post hysterectomy for benign disease.
Farghaly H; Bourgeois D; Houser PM; Padmanabhan V; Lage JM; Hoda RS
Diagn Cytopathol; 2006 Sep; 34(9):640-3. PubMed ID: 16900480
[TBL] [Abstract][Full Text] [Related]
2. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
4. Vaginal Pap tests status-post hysterectomy.
Pantanowitz L; Hornish M; Florence R; Goulart R
Diagn Cytopathol; 2007 Aug; 35(8):539-40. PubMed ID: 17636499
[No Abstract] [Full Text] [Related]
5. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening among women by hysterectomy status and among women aged ≥65 years - United States, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Jan; 61(51-52):1043-7. PubMed ID: 23282862
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening among women without a cervix.
Sirovich BE; Welch HG
JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
[TBL] [Abstract][Full Text] [Related]
8. Correlates of intent to seek unnecessary pap tests among elderly women.
Zhang Y; Borders TF; Rohrer JE
Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
[TBL] [Abstract][Full Text] [Related]
9. Clinical inquiries. Is there any benefit to Papanicolaou (Pap) test screening in women who have had a hysterectomy for benign disease?
Stevermer JJ; Wung L
J Fam Pract; 2001 Feb; 50(2):111-2. PubMed ID: 11219556
[No Abstract] [Full Text] [Related]
10. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
Caraway NP; Khanna A; Dawlett M; Guo M; Guo N; Lin E; Katz RL
Gynecol Oncol; 2008 Jul; 110(1):37-42. PubMed ID: 18433848
[TBL] [Abstract][Full Text] [Related]
11. Prediction of persistent vaginal intraepithelial neoplasia in previously hysterectomized women by high-risk HPV DNA detection.
Frega A; French D; Piazze J; Cerekja A; Vetrano G; Moscarini M
Cancer Lett; 2007 May; 249(2):235-41. PubMed ID: 17070990
[TBL] [Abstract][Full Text] [Related]
12. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
13. Vaginal intraepithelial neoplasia III detected after hysterectomy for benign conditions.
Ferris DG; Messing MJ; Crosby JH
J Fam Pract; 1995 Jan; 40(1):81-5. PubMed ID: 7807042
[TBL] [Abstract][Full Text] [Related]
14. Many unnecessary Pap smears are performed after hysterectomy.
J Fam Pract; 2004 Sep; 53(9):682, 685. PubMed ID: 15353152
[No Abstract] [Full Text] [Related]
15. Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
Santillan A; Govan L; Zahurak ML; Diaz-Montes TP; Giuntoli RL; Bristow RE
Gynecol Oncol; 2008 Jun; 109(3):388-93. PubMed ID: 18405946
[TBL] [Abstract][Full Text] [Related]
16. Is there a language divide in pap test use?
Ponce NA; Chawla N; Babey SH; Gatchell MS; Etzioni DA; Spencer BA; Brown ER; Breen N
Med Care; 2006 Nov; 44(11):998-1004. PubMed ID: 17063131
[TBL] [Abstract][Full Text] [Related]
17. Barriers and facilitators of cervical cancer screening among Hispanic women.
Byrd TL; Chavez R; Wilson KM
Ethn Dis; 2007; 17(1):129-34. PubMed ID: 17274222
[TBL] [Abstract][Full Text] [Related]
18. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).
Eltoum IA; Roberson J
Cancer; 2007 Feb; 111(1):34-40. PubMed ID: 17262799
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for recurrence of vaginal intraepithelial neoplasia in the vaginal vault after laser vaporization.
Kim HS; Park NH; Park IA; Park JH; Chung HH; Kim JW; Song YS; Kang SB
Lasers Surg Med; 2009 Mar; 41(3):196-202. PubMed ID: 19291750
[TBL] [Abstract][Full Text] [Related]
20. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
